All News Peak Bio, Inc.

Equities

PKBO

US70470P1084

Market Closed - OTC Markets Other stock markets 02:27:45 2024-05-09 pm EDT			5-day change	1st Jan Change
0.0086 ^USD	0.00%		0.00%	-95.41%

Mar. 05	Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc..	CI
Feb. 16	Peak Bio, Inc. announced that it has received $2.238 million in funding	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Akari Therapeutics, Plc entered into a definitive agreement to acquire Peak Bio, Inc..	Mar. 04	CI
Peak Bio, Inc. announced that it has received $2.238 million in funding	Feb. 15	CI
Peak Bio, Inc. Receives Loan in the Principal Amount of $750,000	Jan. 29	CI
Peak Bio, Inc. announced that it has received $0.075 million in funding	Jan. 22	CI
Peak Bio, Inc. Awarded Patent with Broad Coverage for Thailanstatin-ADC platform technology (PH-1) a Payload with Novel Immunomodulatory Effects that Target RNA Splicing	Jan. 04	GL
Peak Bio, Inc. announced a financing transaction	Dec. 17	CI
Peak Bio : Private Placement - Form 8-K	Nov. 02	PU
Peak Bio, Inc. Announces Filing of Provisional Patent Applications for PH-1, a Novel and Specific Immunomodulatory ADC payload platform targeting RNA splicing	23-09-19	GL
Peak Bio, Inc. Announces Up-listing to OTCQB Market	23-08-31	GL
Peak Bio, Inc. Announces Up-listing to OTCQB Market	23-08-31	AQ
Peak Bio, Inc. Appoints Michael Friedman to Board of Directors and Member of Audit Committee and Compensation Committee	23-08-31	CI
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	23-08-31	GL
Peak Bio, Inc., Announces Appointment of Michael Friedman to Board of Directors	23-08-31	AQ
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	23-08-29	GL
Peak Bio, Inc. Announces its Application to Uplist to the OTCQB Venture Market	23-08-29	AQ
Peak Bio, Inc. Announces Amendment and Continued Access to Equity Line of up to $100 Million USD via an Accelerated Common Stock Purchase Transaction with White Lion Capital	23-08-24	GL
Peak Bio, Inc. announced that it expects to receive $100 million in funding from White Lion Capital Llc	23-08-23	CI
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting	23-08-23	GL
Peak Bio, Inc. Presents Preclinical Data Highlighting Potential of Differentiated Trop2 PH1 (Novel Payload) ADC in Poster at 2023 AACR Annual Meeting	23-08-23	AQ
Peak Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Peak Bio, Inc.

Equities

PKBO

US70470P1084

All News

Filters